Artiklar/Studier
|
Här har vi samlat intressanta artiklar och studier om Pueraria Mirifica och naturlig bröstförstoring. |
| Efficacy and safety of phytoestrogen, Pueraria Mirifica |
| Pretreatment with phytoestrogen-rich plant decreases breast tumor incidence. |
| Efficacy and safety of Pueraria mirifica (Kwao Kruea Khao) |
| Effect of Pueraria mirifica on vaginal health |
| Pueraria mirifica, a phytoestrogen-rich herb, prevents bone loss |
Pueraria Mirifica on Premenopausal WomenKälla: Chulalongkorn University
The results are summarized in following details as in below: The placebo group contains 31 testers, had received tapioca starch filled capsule to consume 2 capsules/day for 15 days/month started from the first day of the menstruation period, for 2 consecutive months. This group showed no significance change in all record parameters. The first tested group contains 32 testers, had received 400 mg - Pueraria mirifica filled capsule in the same condition as the placebo group. This group showed significance change with different number in all recorded parameters, including mammary pain (44%) which is related to Breast firmness and may relate also to breast enlargement, skin recovering (88%), healthier hair (75%), charisma clearance (100%), increase vaginal secretion (44%), healthier menstruation (6%), breast firmness (44%), breast enlargement (9%), and hip enlargement (9%) The second tested group contains 34 testers, had received 800 mg - Pueraria mirifica filled capsule to consume in the same condition as the placebo group. This group showed significant change with higher number in all recorded parameters, including mammary pain (94%), skin recovering (94%), healthier hair (88%), charisma clearance (100%), increase vaginal secretion (85%), healthier menstruation (29%), breast firmness (94%), breast enlargement (88%), and hip enlargement (9%). Some subjects claimed that the high blood cholesterol levels also decreased. Conclusion: |
Pueraria mirifica clinical study in premenopausal womenKälla: Medical Plant Research Institute Department of Medical Sciences, Ministry of Public Health, Thailand.The results are summarized in following details as in below; The placebo group contains 31 testers, had received tapioca starch filled capsule to consume 2 capsules/day for 15 days/month started from the first day of the menstruation period, for 2 consecutive months. This group showed no significance change in all record parameters. The first tested group contains 32 testers, had received 200 mg @ 2 capsules each per day of Pueraria mirifica filled capsule in the same condition as the placebo group. Conclusion: |
Case Control Study of Phytoestrogens and Reduction in breast-cancer riskKälla: David Ingram, Katherine Sanders, Marlene Kolybaba. Derrick Lopez, University Department of Surgery, Queen Elizabeth II Medical Centre, Perth, Western Australia.Summary: Background Phytoestrogens are a group of naturally occurring chemicals derived from plants: they have a structure similar to estrogen, and form part of our diet. They also have potentially anticarcinogenic biological activity. We did a case-control study to assess the association between phytoestrogen intake (as measured by urinary excretion) and the risk of breast cancer. Methods: Women with newly diagnosed early breast cancer were interviewed by means of questionnaires, and a 72 h urine collection and blood sample were taken before any treatment started. Controls were randomly selected from the electoral roll after matching for age and area of residence. 144 pairs were included for analysis. The urine samples were assayed for the isoflavonic phytoestrogens daidzein, genistein, and equol, and the lignans enterodiol, enterolactone, and matairesinol. Findings: After adjustment for age at menarche, parity, alcohol intake, and total fat intake, high excretion of both equol and enterolactone was associated with a substantial reduction in breast-cancer risk, with significant trends through the quartiles: equol odds ratios were 1.00. 0-45 (95% Cl 0.20, 1.02), 0.52 (0.23, 1.17), and 0.27 (0.10,0.69)—trend p=0.009—and enterolactone odds ratios were 1.00, 0.91 (0.4, 1.98), 0.65 (0.29, 1.44), 0.36(0.15, 0.86)—trend p=0.013. For most other phytoestrogens there was a reduction in risk. but it did not reach significance. Difficulties with the genistein assay precluded analysis of that substance. Interpretation: There is a substantial reduction in breast-cancer risk among women with a high intake (as measured by excretion) of phytoestrogens, particularly the isoflavonic phytoestrogen equol and the lignan enterolactone. These findings could be important in the prevention of breast cancer. |










